Eigo Shimizu

15.7k total citations · 1 hit paper
32 papers, 591 citations indexed

About

Eigo Shimizu is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Eigo Shimizu has authored 32 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Eigo Shimizu's work include Cancer Genomics and Diagnostics (8 papers), Acute Myeloid Leukemia Research (5 papers) and Genetic factors in colorectal cancer (5 papers). Eigo Shimizu is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Acute Myeloid Leukemia Research (5 papers) and Genetic factors in colorectal cancer (5 papers). Eigo Shimizu collaborates with scholars based in Japan, United States and United Kingdom. Eigo Shimizu's co-authors include Seiya Imoto, Yoichi Furukawa, Seira Hatakeyama, Kiyoshi Yamaguchi, Teh‐Wei Wang, Makoto Nakanishi, Yoshikazu Johmura, Satotaka Omori, Satoshi Yamazaki and Akihiko Yoshimura and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Eigo Shimizu

30 papers receiving 587 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blocking PD-L1–PD-1 improves senescence surveillance and ageing phenotypes

2022 278 citations Teh‐Wei Wang, Yoshikazu Johmura et al. Nature profile →

Peers

Countries citing papers authored by Eigo Shimizu

Since Specialization

Citations

This map shows the geographic impact of Eigo Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eigo Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eigo Shimizu more than expected).

Fields of papers citing papers by Eigo Shimizu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eigo Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eigo Shimizu. The network helps show where Eigo Shimizu may publish in the future.

Co-authorship network of co-authors of Eigo Shimizu

This figure shows the co-authorship network connecting the top 25 collaborators of Eigo Shimizu. A scholar is included among the top collaborators of Eigo Shimizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eigo Shimizu. Eigo Shimizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preexisting senescent fibroblasts in the aged bladder create a tumor-permissive niche through CXCL12 secretion 2024 ·Nature Aging ·(unknown), Yoshikazu Johmura, Teh‐Wei Wang, (unknown), (unknown), Satotaka Omori, Y Okamura, Seiji Hoshi, (unknown), Kiyoshi Yamaguchi, Seira Hatakeyama, Satoshi Yamazaki, Eigo Shimizu, Seiya Imoto, Yoichi Furukawa, Yoshiyuki Kojima, Makoto Nakanishi	16
2	Genetic analysis of low-grade adenosquamous carcinoma of the breast progressing to high-grade metaplastic carcinoma 2023 ·Breast Cancer Research and Treatment ·Kae Kawachi, Xiaoyan Tang, Rika Kasajima, Takashi Yamanaka, Eigo Shimizu, Kotoe Katayama, Rui Yamaguchi, Kazuaki Yokoyama, Kiyoshi Yamaguchi, Yoichi Furukawa, Satoru Miyano, Seiya Imoto, Emi Yoshioka, Kota Washimi, Yoichiro Okubo, Shinya Sato, Tomoyuki Yokose, Yohei Miyagi	3
3	Clinical and prognostic features of Langerhans cell histiocytosis in adults 2023 ·Cancer Science ·Aki Sato, Masayuki Kobayashi, (unknown), Miho Ogawa, Eigo Shimizu, Toyotaka Kawamata, Kazuaki Yokoyama, Yasunori Ota, Tatsuo Ichinohe, Hitoshi Ohno, Yasuo Mori, Emiko Sakaida, Tadakazu Kondo, Seiya Imoto, Yasuhito Nannya, Kinuko Mitani, Arinobu Tojo	7
4	KMT2C expression and DNA homologous recombination repair factors in lung cancers with a high-grade fetal adenocarcinoma component 2023 ·Translational Lung Cancer Research ·Masaki Suzuki, Rika Kasajima, Tomoyuki Yokose, Eigo Shimizu, Seira Hatakeyama, Kiyoshi Yamaguchi, Kazuaki Yokoyama, Kotoe Katayama, Rui Yamaguchi, Yoichi Furukawa, Satoru Miyano, Seiya Imoto, Aya Shinozaki‐Ushiku, Tetsuo Ushiku, Yohei Miyagi	2
5	Blocking PD-L1–PD-1 improves senescence surveillance and ageing phenotypes breakdown → 2022 ·Nature ·Teh‐Wei Wang, Yoshikazu Johmura, Narumi Suzuki, Satotaka Omori, Toshiro Migita, Kiyoshi Yamaguchi, Seira Hatakeyama, Satoshi Yamazaki, Eigo Shimizu, Seiya Imoto, Yoichi Furukawa, Akihiko Yoshimura, Makoto Nakanishi	278
6	Case report: Common clonal origin of concurrent langerhans cell histiocytosis and acute myeloid leukemia 2022 ·Frontiers in Oncology ·(unknown), Kazuaki Yokoyama, (unknown), (unknown), (unknown), Masahiko Sumi, Ichiro Ito, (unknown), Rika Kasajima, Eigo Shimizu, Rui Yamaguchi, Seiya Imoto, Satoru Miyano, Yukihisa Tanaka, (unknown), Yasunori Ota, Arinobu Tojo, (unknown)	2
7	Anti-inflammatory effects of ruxolitinib on chronic neutrophilic leukemia harboring CSF3R-T618I mutation with bilateral renal abscesses 2022 ·Leukemia Research Reports ·(unknown), Kazuaki Yokoyama, Takashi Matsunaga, Shinsuke Kitahara, Tomoki Fujii, Seiichiro Kobayashi, (unknown), Eigo Shimizu, Seiya Imoto, Arinobu Tojo, Nobuhiro Ohno	0
8	Comprehensive molecular analysis of genomic profiles and PD-L1 expression in lung adenocarcinoma with a high-grade fetal adenocarcinoma component 2021 ·Translational Lung Cancer Research ·Masaki Suzuki, Rika Kasajima, Tomoyuki Yokose, Hiroyuki Ito, Eigo Shimizu, Seira Hatakeyama, Kazuaki Yokoyama, Rui Yamaguchi, Yoichi Furukawa, Satoru Miyano, Seiya Imoto, Emi Yoshioka, Kota Washimi, Yoichiro Okubo, Kae Kawachi, Shinya Sato, Yohei Miyagi	10
9	Immunogenomic pan-cancer landscape reveals immune escape mechanisms and immunoediting histories 2021 ·Scientific Reports ·Shinichi Mizuno, Rui Yamaguchi, Takanori Hasegawa, Shuto Hayashi, Masashi Fujita, Fan Zhang, Youngil Koh, (unknown), Sung‐Soo Yoon, Eigo Shimizu, Mitsuhiro Komura, Akihiro Fujimoto, Momoko Nagai, Mamoru Kato, Han Liang, Satoru Miyano, Zemin Zhang, Hidewaki Nakagawa, Seiya Imoto	10
10	Neoantimon: a multifunctional R package for identification of tumor-specific neoantigens 2020 ·Bioinformatics ·Takanori Hasegawa, Shuto Hayashi, Eigo Shimizu, Shinichi Mizuno, Atsushi Niida, Rui Yamaguchi, Satoru Miyano, Hidewaki Nakagawa, Seiya Imoto	9
11	Association of single nucleotide polymorphisms in the NRF2 promoter with vascular stiffness with aging 2020 ·PLoS ONE ·Sunao Shimizu, Junsei Mimura, Takanori Hasegawa, Eigo Shimizu, Seiya Imoto, (unknown), Shuya Kasai, Hiromi Yamazaki, Yusuke Ushida, Hiroyuki Suganuma, Hirofumi Tomita, Masayuki Yamamoto, Shigeyuki Nakaji, Ken Itoh	9
12	Development of an MSI-positive colon tumor with aberrant DNA methylation in a PPAP patient 2019 ·Journal of Human Genetics ·Kiyoshi Yamaguchi, Eigo Shimizu, Rui Yamaguchi, Seiya Imoto, Mitsuhiro Komura, Seira Hatakeyama, Rei Noguchi, (unknown), Tsuneo Ikenoue, (unknown), Hideaki Yano, Satoru Miyano, Yoichi Furukawa	7
13	Prognostic impact of circulating tumor DNA status post–allogeneic hematopoietic stem cell transplantation in AML and MDS 2019 ·Blood ·(unknown), Kazuaki Yokoyama, Eigo Shimizu, (unknown), (unknown), Miho Ogawa, (unknown), Asako Kobayashi, Mika Ito, Masamichi Isobe, Takaaki Konuma, Seiko Kato, Rika Kasajima, Yuka Wada, Tokiko Nagamura‐Inoue, Rui Yamaguchi, Satoshi Takahashi, Seiya Imoto, Satoru Miyano, Arinobu Tojo	71
14	An Unusually Short Latent Period of Therapy-Related Myeloid Neoplasm Harboring a Rare MLL-EP300 Rearrangement: Case Report and Literature Review 2019 ·SHILAP Revista de lepidopterología ·Reina Takeda, Kazuaki Yokoyama, Seiichiro Kobayashi, Toyotaka Kawamata, (unknown), Tomofusa Fukuyama, Mika Ito, (unknown), Eigo Shimizu, Nobuhiro Ohno, Rui Yamaguchi, Seiya Imoto, Satoru Miyano, Kaoru Uchimaru, Arinobu Tojo	1
15	Cell-lineage level–targeted sequencing to identify acute myeloid leukemia with myelodysplasia-related changes 2018 ·Blood Advances ·Kazuaki Yokoyama, Eigo Shimizu, (unknown), (unknown), Rika Kasajima, Miho Ogawa, (unknown), Mika Ito, Asako Kobayashi, Rui Yamaguchi, Seiya Imoto, Satoru Miyano, Arinobu Tojo	8
16	Circulating tumor DNA dynamically predicts response and/or relapse in patients with hematological malignancies 2018 ·International Journal of Hematology ·(unknown), Kazuaki Yokoyama, (unknown), Miho Ogawa, (unknown), Asako Kobayashi, Mika Ito, Eigo Shimizu, Rika Kasajima, Yuka Wada, Rui Yamaguchi, Seiya Imoto, Tokiko Nagamura‐Inoue, Satoru Miyano, Arinobu Tojo	16
17	Requirement of glycosylation machinery in TLR responses revealed by CRISPR/Cas9 screening 2017 ·International Immunology ·Ryota Sato, Takuma Shibata, Yu Tanaka, (unknown), Kiyoshi Yamaguchi, Yoichi Furukawa, Eigo Shimizu, Rui Yamaguchi, Seiya Imoto, Satoru Miyano, Kensuke Miyake	9
18	Detection of APC mosaicism by next-generation sequencing in an FAP patient 2015 ·Journal of Human Genetics ·Kiyoshi Yamaguchi, Mitsuhiro Komura, Rui Yamaguchi, Seiya Imoto, Eigo Shimizu, (unknown), Tetsuo Shibuya, Seira Hatakeyama, Norihiko Takahashi, Tsuneo Ikenoue, Keisuke Hata, Giichiro Tsurita, Masaru Shinozaki, Yutaka Suzuki, Sumio Sugano, Satoru Miyano, Yoichi Furukawa	28
19	Stability of miRNA 5′terminal and seed regions is correlated with experimentally observed miRNA-mediated silencing efficacy 2012 ·Scientific Reports ·(unknown), Kimihiro Hino, Eigo Shimizu, (unknown), Kumiko Ui‐Tei	56
20	[Philadelphia chromosome positive acute myelomonocytic leukemia]. 1988 ·PubMed ·(unknown), Masato Moriyama, Y Sakagami, Yasumasa Okamoto, Eigo Shimizu, Masahiro Tsujimoto, Ota K, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact